Panel members provide information on HE and its symptoms, precipitants, and treatment.
July 2019
As the deadline for full implementation approaches, hospitals must create an action plan and timeline for completion.
Pharmacists should develop treatment plans with an active interdisciplinary team and patient involvement.
Defining multiple sclerosis helps pinpoint what therapies work best for patients.
The United States is on the cusp of seeing significantly more activity related to these products.
That is the message that pharmacy leaders must send to payers and pharmacy benefit managers.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Estradiol-Containing MHT May Impact Alzheimer Disease-Related Biomarkers in Postmenopausal Women
2
CHEST 2025: Improving Access to Chronic Cough Treatment Through a Digital Therapeutic Solution
3
CHEST 2025: Brensocatib Shows Potential to Slow Structural Lung Changes in Bronchiectasis
4
What to Know About the Latest Pediatric Respiratory Infections
5
